← Back to Search

Other

Digihaler Albuterol Device by TEVA for Childhood Asthma

N/A
Waitlist Available
Led By Neema Izadi, MD
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients 8 to <19 years of age with a diagnosis of asthma as ICD-9 code 493 or ICD-10 code J45 seen in the allergy clinic at CHLA who have an albuterol rescue inhaler already prescribed and access to a personal smartphone will be eligible for recruitment.
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test whether an electronic albuterol rescue inhaler can help improve asthma management in a mostly minority and inner-city population of children.

Eligible Conditions
  • Childhood Asthma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Albuterol Use
Asthma Adherence
Asthma Outcomes
Secondary outcome measures
Asthma Quality of Life
Lung Function
Spirometry

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients 8 to <19 years of age with a diagnosis of asthmaExperimental Treatment1 Intervention
Patients 8 to <19 years of age with a diagnosis of asthma as ICD-9 code 493 or ICD-10 code J45 seen in the allergy clinic at CHLA who have an albuterol rescue inhaler already prescribed and access to a personal smartphone will be eligible for recruitment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digihaler Albuterol Device by TEVA
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Children's Hospital Los AngelesLead Sponsor
232 Previous Clinical Trials
5,076,747 Total Patients Enrolled
Teva Pharmaceuticals USAIndustry Sponsor
230 Previous Clinical Trials
188,179 Total Patients Enrolled
Neema Izadi, MDPrincipal InvestigatorChildren's Hospital Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is this medical experiment available?

"This research project is seeking 40 children with asthma between 8 and 18 years old. To be eligible, prospective participants must have an ICD-9 or 10 code related to asthma, a prescribed albuterol inhaler, access to their own smartphone device, and prior visits to the CHLA allergy clinic."

Answered by AI

Are recruitment initiatives for this research currently underway?

"Affirmative. The clinical trial, which was first advertised on June 1st 2021, is in the midst of recruitment according to information provided by clinicaltrials.gov. 40 participants are required from 1 medical centre for this research project."

Answered by AI

Are individuals under 25 years of age eligible to join this research study?

"According to the requirements of this clinical trial, participants must be between 8 and 18 years old. 121 trials are currently recruiting minors while 199 trials cater to seniors over 65."

Answered by AI

How many individuals have opted to participate in this research endeavor?

"Verified. According to the information housed on clinicaltrials.gov, this trial is actively recruiting members and has been since June 2021 when it was initially posted. The latest update came in March 2022 and 40 participants are needed from just one medical facility."

Answered by AI
~5 spots leftby Apr 2025